Wagner Wealth Management (South Carolina)’s Vertex Pharmaceuticals VRTX Stock Holding History

Wagner Wealth Management (South Carolina)’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-100	Closed	-$29K	–	682
2022 Q3	$29K	Sell	100 -134	-57%	-$38.6K	0.02%	261
2022 Q2	$66K	Buy	+234	New	+$62.6K	0.05%	177
2022 Q1	–	Sell	-100	Closed	-$22K	–	644
2021 Q4	$22K	Hold	100	–	–	0.02%	388
2021 Q3	$18K	Hold	100	–	–	0.01%	393
2021 Q2	$20K	Hold	100	–	–	0.01%	386
2021 Q1	$21K	Buy	+100	New	+$22K	0.02%	359
2018 Q3	$19K	Hold	100	–	–	0.01%	354
2018 Q2	$17K	Buy	100 +35	+54%	+$5.42K	0.01%	334
2018 Q1	$11K	Buy	65 +9	+16%	+$1.47K	0.01%	361
2017 Q4	$9K	Buy	+56	New	+$8.29K	0.01%	427

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Wagner Wealth Management (South Carolina)'s VRTX Position: Q4 2022 in Review

Wagner Wealth Management (South Carolina) sold out of Vertex Pharmaceuticals (VRTX) in Q4 2022, closing a stake of 100 shares — an estimated $29K sold.

Wagner Wealth Management (South Carolina) first reported a position in VRTX in Q4 2017 and held it in 10 quarters. The position peaked at $66K in Q2 2022. 1,223 funds tracked by Wall St. Rank hold VRTX as of Q4 2022.

Wagner Wealth Management (South Carolina) reported no remaining Vertex Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Wagner Wealth Management (South Carolina) sold 100 Vertex Pharmaceuticals shares in Q4 2022, an estimated $29K.
Wagner Wealth Management (South Carolina) first reported a position in Vertex Pharmaceuticals in Q4 2017 and held it in 10 quarters.
Wagner Wealth Management (South Carolina)'s Vertex Pharmaceuticals position peaked at $66K in Q2 2022.
1,223 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2022.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q4 2022, filed 14 Feb 2023.